AKT1 and colonic neoplasm: Additionally, apigenin suppresses the mTOR/PI3K/AKT signaling pathway, thereby promoting autophagy in erythroid subtype leukemia (TF-1), liver cancer (Hep G2), and colon cancer (HT-29) cells [67–70].